RT Journal Article
SR Electronic
T1 The effect of artificial oocyte activation on blastocysts rate in patients with low blastocyst rates: A retrospective cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.28.24309669
DO 10.1101/2024.06.28.24309669
A1 Sendy, Feras
A1 Hemmings, Robert
A1 Kadoch, Isaac-Jacques
A1 Jamal, Wael
A1 Phillips, Simon
YR 2024
UL http://medrxiv.org/content/early/2024/06/30/2024.06.28.24309669.abstract
AB Introduction Physiological oocyte activation requires a synergy between the oocyte and sperm to release calcium (Ca2+) through oscillations. The absence of such synergy between the oocyte and sperm leads to a negative impact on oocyte activation. Studies have shown that Artificial oocyte activation (AOA) is helpful in cases with failed or low fertilization rates. Studies present mixed opinions about increasing blastocyst rate.Methods A retrospective cohort single-center study was performed between January 2018 and October 2023, including 54 couples with suboptimal blastocyst development. The study compared intracytoplasmic sperm injection (ICSI) AOA cycles with previous conventional ICSI cycles and conventional ICSI without AOA cycles with previous conventional ICSI cycles in couples with failed or low blastocyst rates (< 30%) in the original ICSI cycle.Results We compared 22 AOA cycles to previous conventional ICSI cycles in the same patients and 32 conventional ICSI cycles without AOA to previous conventional ICSI cycles in the same patients. After AOA, the blastocyst rate was not significantly higher than the control group (48% vs 29% p=0.19). Conversely, the blastocyst rate was significantly higher in the conventional ICSI without AOA cycles than in the control group (48% vs 24% p=0.04). The fertilization rate was not statistically significant between the first and second cycles in both groups.Conclusion The literature still lacks strong evidence for AOA overcoming impaired embryonic development. Therefore, AOA remains reserved for couples with a failed or low fertilization history to improve fertilization results. Optimal laboratory conditions and ovarian stimulation modifications without AOA may improve blastocyst rates.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialClinicaltrial.gov: NCT06290895Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ovo fertility clinic Ethical :VeritasIRB approbation number: 2024-3465-17162-3I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript